Publications by authors named "Chase Board"

Claim this Profile
P
PCSK9 Inhibitors in Secondary Prevention-An Opportunity for Personalized Therapy.
Chase Board, Michael S Kelly, Michael D Shapiro, Dave L Dixon

J Cardiovasc Pharmacol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
You don't need a title to lead.
Chase Board

J Am Pharm Assoc (2003)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lesinurad, a Selective URAT-1 Inhibitor With a Novel Mechanism in Combination With a Xanthine Oxidase Inhibitor, for Hyperuricemia Associated With Gout.
Emily Huneycutt, Chase Board, Jennifer N Clements

J Pharm Pract· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis